Cargando…

A novel immune-related genes prognosis biomarker for hepatocellular carcinoma

Background: Hepatocellular carcinoma (HCC) is closely associated with the immune microenvironment. To identify the effective population before administering treatment, the establishment of prognostic immune biomarkers is crucial for early HCC diagnosis and treatment. Results: A total of 335 IRGs ide...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Kunpeng, Chen, Xinyi, Jin, Chong, Mo, Jinggang, Jiang, Hao, Yi, Bin, Chen, Xiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834986/ https://www.ncbi.nlm.nih.gov/pubmed/33260154 http://dx.doi.org/10.18632/aging.202173

Ejemplares similares

Combination of Ablation and Immunotherapy for Hepatocellular Carcinoma: Where We Are and Where to Go
por: Wang, Kunpeng, et al.
Publicado: (2021)

Selective Inhibitor of the c-Met Receptor Tyrosine Kinase in Advanced Hepatocellular Carcinoma: No Beneficial Effect With the Use of Tivantinib?
por: Zhao, Shankun, et al.
Publicado: (2021)

Roles of hypoxia-inducible factor in hepatocellular carcinoma under local ablation therapies
por: Xiao, Chunying, et al.
Publicado: (2023)

The multikinase inhibitor axitinib in the treatment of advanced hepatocellular carcinoma: the current clinical applications and the molecular mechanisms
por: Jiang, Hao, et al.
Publicado: (2023)

The novel immune-related genes predict the prognosis of patients with hepatocellular carcinoma
por: Li, Lunxu, et al.
Publicado: (2021)

Noninvasive Identification of Immune-Related Biomarkers in Hepatocellular Carcinoma
por: Li, Ling, et al.
Publicado: (2019)

A novel immune signature to predict the prognosis of patients with hepatocellular carcinoma
por: Li, Qinghe, et al.
Publicado: (2021)

TMEM147 is a novel biomarker for diagnosis and prognosis of hepatocellular carcinoma
por: Fan, Wen-Jie, et al.
Publicado: (2023)

Comprehensive Analysis of Immune-Related Prognosis of TK1 in Hepatocellular Carcinoma
por: Cai, Qun, et al.
Publicado: (2022)

HBV DNA integrates into upregulated ZBTB20 in patients with hepatocellular carcinoma
por: He, Zebao, et al.
Publicado: (2020)

A novel immune-related gene signature predicts the prognosis of hepatocellular carcinoma
por: He, Shujiao, et al.
Publicado: (2022)

A novel disulfidptosis-related immune checkpoint genes signature: forecasting the prognosis of hepatocellular carcinoma
por: Chen, Yuxin, et al.
Publicado: (2023)

Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma
por: Hu, Xiaoyi, et al.
Publicado: (2020)

Identification METTL18 as a Potential Prognosis Biomarker and Associated With Immune Infiltrates in Hepatocellular Carcinoma
por: Li, Tian-Hao, et al.
Publicado: (2021)

Comprehensive analysis of cuproptosis-related lncRNAs in immune infiltration and prognosis in hepatocellular carcinoma
por: Liu, Chunhua, et al.
Publicado: (2023)

Integrated Analysis of Immunity- and Ferroptosis-Related Biomarker Signatures to Improve the Prognosis Prediction of Hepatocellular Carcinoma
por: Du, Xuanlong, et al.
Publicado: (2020)

Nuf2 Is a Prognostic-Related Biomarker and Correlated With Immune Infiltrates in Hepatocellular Carcinoma
por: Xie, Xingwei, et al.
Publicado: (2021)

Six immune-related promising biomarkers may promote hepatocellular carcinoma prognosis: a bioinformatics analysis and experimental validation
por: Lin, Xia-Hui, et al.
Publicado: (2023)

A novel hepatocellular carcinoma-specific mTORC1-related signature for anticipating prognosis and immunotherapy
por: Chen, Erbao, et al.
Publicado: (2023)

A novel necroptosis-related lncRNA signature predicts the prognosis and immune microenvironment of hepatocellular carcinoma
por: Wang, Jianguo, et al.
Publicado: (2022)

Beta2-Microglobulin as Predictive Biomarkers in the Prognosis of Hepatocellular Carcinoma and Development of a New Nomogram
por: Lin, Qiumei, et al.
Publicado: (2023)

Comprehensive Analysis of the Expression and Prognosis for Lipid Metabolism-Related Genes in Hepatocellular Carcinoma
por: Fan, Wen-Jie, et al.
Publicado: (2022)

Cortactin is a sensitive biomarker relative to the poor prognosis of human hepatocellular carcinoma
por: Zhao, Gang, et al.
Publicado: (2013)

Exosome Cargos as Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma
por: Zeng, Yulai, et al.
Publicado: (2023)

The Novel-Natural-Killer-Cell-Related Gene Signature Predicts the Prognosis and Immune Status of Patients with Hepatocellular Carcinoma
por: Li, Minjun, et al.
Publicado: (2023)

An anoikis-related gene signature predicts prognosis and reveals immune infiltration in hepatocellular carcinoma
por: Chen, Yang, et al.
Publicado: (2023)

Micro1278 Leads to Tumor Growth Arrest, Enhanced Sensitivity to Oxaliplatin and Vitamin D and Inhibits Metastasis via KIF5B, CYP24A1, and BTG2, Respectively
por: Lin, Weidong, et al.
Publicado: (2021)

Corrigendum: Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma
por: Hu, Xiaoyi, et al.
Publicado: (2020)

A robust twelve-gene signature for prognosis prediction of hepatocellular carcinoma
por: Ouyang, Guoqing, et al.
Publicado: (2020)

In-depth characterization of the biomarkers based on tumor-infiltrated immune cells reveals implications for diagnosis and prognosis in hepatocellular carcinoma
por: Chen, Wenbiao, et al.
Publicado: (2020)

PIK3R3 is upregulated in liver cancer and activates Akt signaling to control cancer growth by regulation of CDKN1C and SMC1A
por: Lin, Weidong, et al.
Publicado: (2023)

A novel signature incorporating lipid metabolism- and immune-related genes to predict the prognosis and immune landscape in hepatocellular carcinoma
por: Yang, Ti, et al.
Publicado: (2023)

Ferroptosis-related lncRNA signature predicts the prognosis and immune microenvironment of hepatocellular carcinoma
por: Fang, Chongkai, et al.
Publicado: (2022)

Development and verification of the glycolysis-associated and immune-related prognosis signature for hepatocellular carcinoma
por: Hu, Bo, et al.
Publicado: (2022)

An Integrating Immune-Related Signature to Improve Prognosis of Hepatocellular Carcinoma
por: Zhu, Rui, et al.
Publicado: (2020)

A Novel Epithelial-Mesenchymal Transition Gene Signature Correlated With Prognosis, and Immune Infiltration in Hepatocellular Carcinoma
por: Kong, Weihao, et al.
Publicado: (2022)

The Immune-Related Gene ELF3 is a Novel Biomarker for the Prognosis of Ovarian Cancer
por: Xu, Hao, et al.
Publicado: (2021)

Identification of a Novel Metastasis-Related miRNAs-Based Signature for Predicting the Prognosis of Hepatocellular Carcinoma
por: Chen, Yuan, et al.
Publicado: (2021)

Recent advances in optical aptasensors for biomarkers in early diagnosis and prognosis monitoring of hepatocellular carcinoma
por: Dong, Jia-Mei, et al.
Publicado: (2023)

An immune-related signature for optimizing prognosis prediction and treatment decision of hepatocellular carcinoma
por: Yao, Ninghua, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_583co65g9stj6rtt9n5b99sls2